Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update

Go back to Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update
(NASDAQ: ACXP) Delayed: 1.57 -0.08 (4.85%)
Previous Close $1.65    52 Week High
Open $1.63    52 Week Low
Day High $1.65    P/E N/A 
Day Low $1.56    EPS
Volume 52,199